M

MarsBio

2 employees

Synbio + biotech + deep tech venture capital fund. Investing in pre-seed & seed stage companies.

Investor insights

Sectors invested in

Biotechnology3
Agriculture2
Nanotechnology1
Autoimmune Disease1
Tissue Engineering1
Cellular Engineering1
Immunooncology1
Gene Editing1
Health Care1
Nutrition1
Health & Nutrition1
Food & Beverage1
Food Processing1
AgTech1

Funding rounds participated in

$250K sweet spot round size

Most of their 3 investments are in rounds between $2.8M and $7.9M

Basic info

Industry

venture capital and private equity principals

Date founded

2018

Investments made

N

NAPIGEN, INC. raised $7.9M on July 12, 2022

Investors: United Mitochondrial Disease Foundation, The Grantham Foundation for the Protection of the Environment, Breakout Labs, SVG Partners, RA Capital Management, L.P. and MarsBio

K

Karma Biotechnologies raised $2.8M on September 1, 2021

Investors: Calm Ventures, Viva BioInnovator, -, Tuesday Capital, Khosla Ventures, SOSV - The Accelerator VC and MarsBio

S

Spira Inc. raised undisclosed on April 1, 2019

Investors: MarsBio

FAQ